4//SEC Filing
SOLAND DANIEL B 4
Accession 0001209191-23-034699
CIK 0001070494other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 9:46 PM ET
Size
19.0 KB
Accession
0001209191-23-034699
Insider Transaction Report
Form 4
SOLAND DANIEL B
Director
Transactions
- Exercise/Conversion
Restricted Stock Units
2021-06-22−3,059→ 0 total→ Common Stock (3,059 underlying) - Exercise/Conversion
Restricted Stock Units
2023-06-01−8,552→ 0 total→ Common Stock (8,552 underlying) - Award
Director Stock Options (Right to Buy)
2023-06-01+11,045→ 11,045 totalExercise: $23.90Exp: 2033-05-31→ Common Stock (11,045 underlying) - Award
Restricted Stock Units
2023-06-01+6,652→ 6,652 total→ Common Stock (6,652 underlying) - Exercise/Conversion
Common Stock
2023-06-01+8,552→ 28,002 total - Exercise/Conversion
Common Stock
2021-06-22+3,059→ 13,059 total - Exercise/Conversion
Common Stock
2022-06-07+6,391→ 19,450 total - Exercise/Conversion
Restricted Stock Units
2022-06-07−6,391→ 0 total→ Common Stock (6,391 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Acadia common stock.
- [F2]The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date.
- [F3]The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001318485
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 9:46 PM ET
- Size
- 19.0 KB